This includes VAPB-PTPIP51 disruption in induced pluripotent stem cell derived dopaminergic neurons from familial Parkinson’s disease patients carrying pathogenic SNCA (α-synuclein) triplications and in affected neurons in post-mortem Alzheimer’s disease brain [28, 40]. This evidence concerns the gene VAPB and early-onset autosomal dominant Alzheimer disease.